268 results on '"Niknafs, Noushin"'
Search Results
2. DNA methylation and gene expression as determinants of genome-wide cell-free DNA fragmentation
3. ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results
4. Persistent mutation burden drives sustained anti-tumor immune responses
5. Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma.
6. Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial
7. Genome-wide repeat landscapes in cancer and cell-free DNA
8. Supplementary Table S12 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
9. Supplementary Figure S7 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
10. Data from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
11. Matching phenotypes to whole genomes: Lessons learned from four iterations of the personal genome project community challenges
12. Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
13. Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer
14. 604 Clinical and molecular findings from a randomized phase II study of epigenetic priming with azacitidine and entinostat followed by nivolumab in previously treated metastatic non-small cell lung cancer
15. Detection and characterization of lung cancer using cell-free DNA fragmentomes
16. Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer
17. A probabilistic model to predict clinical phenotypic traits from genome sequencing.
18. Genome-wide cell-free DNA fragmentation in patients with cancer
19. Genomic characterization of malignant progression in neoplastic pancreatic cysts
20. Tracing the genetic fingerprints of tumour evolution: The pursuit of identifying mutations with differential weights within the overall tumour mutation burden and their role in therapeutic responses with immune checkpoint blockade
21. Data from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
22. Fig S5 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
23. TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
24. Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
25. Abstract CT212: A ctDNA-directed, multi-center phase II study of molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer: Analysis of Stage 1 of CCTG BR.36
26. Supplementary Tables from Detecting Liver Cancer Using Cell-Free DNA Fragmentomes
27. Abstract 5606: Dynamics of sequence and structural cell-free DNA landscapes in small-cell lung cancer during systemic therapy
28. Data from Detecting Liver Cancer Using Cell-Free DNA Fragmentomes
29. Abstract 773: Early detection of ovarian cancer using cell-free DNA fragmentomes
30. Supplementary Figures S1-S14 from Detecting Liver Cancer Using Cell-Free DNA Fragmentomes
31. Abstract 1393: Persistent mutation burden drives sustained anti-tumor immune responses in human cancers
32. Table S1 from Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma
33. Data from Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer
34. Supplementary Tables S1 - S12 from Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer
35. Supplementary Tables S1 - S18 from Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
36. Supplementary Figures S1 - S16 from Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
37. Data from Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
38. Data from Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma
39. Figure S2 from Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma
40. Supplementary Figure Legends from Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
41. Characterization of genetic subclonal evolution in pancreatic cancer mouse models
42. Supplementary Tables S1-S18 from Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
43. Data from Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure
44. Data from Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
45. Supplementary Materials and Methods and Supplementary Figures 1 through 6 from Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure
46. Supplementary Tables 1-9 from Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure
47. Supplementary Figures S1-S14 from Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
48. Three-dimensional genomic mapping of human pancreatic tissue reveals striking multifocality and genetic heterogeneity in precancerous lesions
49. Detecting liver cancer using cell-free DNA fragmentomes
50. 10. HLA class II Immunogenic Mutation Burden predicts response to immune checkpoint blockade
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.